Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc., 8303-8304 [2025-01766]

Download as PDF 8303 Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and UHD Alliance intends to file additional written notifications disclosing all changes in membership. On June 17, 2015, UHD Alliance filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on July 17, 2015 (80 FR 42537). The last notification was filed with the Department on October 8, 2024. A notice was published in the Federal Register pursuant to section 6(b) of the Act on December 20, 2024 (89 FR 104209). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. antitrust plaintiffs to actual damages under specified circumstances. Specifically, Project Navigator, Ltd. (A Verdantas Company), Tustin, CA, has become a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PERF intends to file additional written notifications disclosing all changes in membership. On February 10, 1986, PERF filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on March 14, 1986 (51 FR 8903). The last notification was filed with the Department on July 15, 2024. A notice was published in the Federal Register pursuant to section 6(h) of the Act on October 11, 2024 (89 FR 82632). Suzanne Morris, Deputy Director Civil Enforcement Operations, Antitrust Division. [FR Doc. 2025–01818 Filed 1–27–25; 8:45 am] BILLING CODE P [FR Doc. 2025–01824 Filed 1–27–25; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Antitrust Division DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993—Petroleum Environmental Research Forum Drug Enforcement Administration Notice is hereby given that, on December 17, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1933, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Petroleum Environmental Research Forum (‘‘PERF’’) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of [Docket No. DEA–1449] Importer of Controlled Substances Application: Vici Health Sciences, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and SUMMARY: applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 27, 2025. Such persons may also file a written request for a hearing on the application on or before February 27, 2025. The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on October 4, 2024, Vici Health Sciences, LLC, 6655 Amberton Drive, Suite O, Elkridge, Maryland 21075–6202 applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Drug code Controlled substance ddrumheller on DSK120RN23PROD with NOTICES1 Fentanyl-related compounds as defined in 21 CFR 1308.11(h) .................................................................................................. The company plans to import the listed controlled substance as part of a manufacturing process supporting research and clinical trial efforts. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug VerDate Sep<11>2014 17:49 Jan 27, 2025 Jkt 265001 Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. PO 00000 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc. Drug Enforcement Administration, Justice. AGENCY: Frm 00047 Fmt 4703 Sfmt 4703 I [Docket No. DEA–1454] [FR Doc. 2025–01767 Filed 1–27–25; 8:45 am] BILLING CODE 4410–09–P 9850 Schedule E:\FR\FM\28JAN1.SGM 28JAN1 8304 ACTION: Federal Register / Vol. 90, No. 17 / Tuesday, January 28, 2025 / Notices Notice of application. Aveva Drug Delivery Systems, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 27, 2025. Such persons may also file a written request for a hearing on the application on or before February 27, 2025. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on October 9, 2024, Aveva Drug Delivery Systems, Inc., 3250 Commerce Parkway, Miramar, Florida 33025–3907, applied to be registered as an importer of the following basic class(es) of controlled substance(s): ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: Drug code Controlled substance Thebaine ........................ I 9333 Schedule III The company plans to import the listed controlled substance for analytical purposes only. No other activity for this drug code is authorized for this registration. VerDate Sep<11>2014 17:49 Jan 27, 2025 Jkt 265001 Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew Strait, Deputy Assistant Administrator. [FR Doc. 2025–01766 Filed 1–27–25; 8:45 am] BILLING CODE 4410–09–P NATIONAL ARCHIVES AND RECORDS ADMINISTRATION [NARA–25–0002; NARA–2025–014] Records Schedules; Availability and Request for Comments National Archives and Records Administration (NARA). ACTION: Notice of availability of proposed records schedules; request for comments. AGENCY: The National Archives and Records Administration (NARA) publishes notice of certain Federal agency requests for records disposition authority (records schedules). We publish notice in the Federal Register and on regulations.gov for records schedules in which agencies propose to dispose of records they no longer need to conduct agency business. We invite public comments on such records schedules. SUMMARY: We must receive responses on the schedules listed in this notice by March 17, 2025. ADDRESSES: To view a records schedule in this notice, or submit a comment on one, use the following address: https:// www.regulations.gov/docket/NARA-250002/document. This is a direct link to the schedules posted in the docket for this notice on regulations.gov. You may submit comments by the following method: Federal eRulemaking Portal: https:// www.regulations.gov. On the website, enter either of the numbers cited at the top of this notice into the search field. This will bring you to the docket for this notice, in which we have posted the records schedules open for comment. Each schedule has a ‘comment’ button so you can comment on that specific schedule. For more information on regulations.gov and on submitting comments, see their FAQs at https:// www.regulations.gov/faq. If you are unable to comment via regulations.gov, you may email us at DATES: PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 request.schedule@nara.gov for instructions on submitting your comment. You must cite the control number of the schedule you wish to comment on. You can find the control number for each schedule in parentheses at the end of each schedule’s entry in the list at the end of this notice. FOR FURTHER INFORMATION CONTACT: Kimberly Richardson, Strategy and Performance Division, by email at regulation_comments@nara.gov or at 301–837–2902. For information about records schedules, contact Records Management Operations by email at request.schedule@nara.gov or by phone at 301–837–1799. SUPPLEMENTARY INFORMATION: Public Comment Procedures We are publishing notice of records schedules in which agencies propose to dispose of records they no longer need to conduct agency business. We invite public comments on these records schedules, as required by 44 U.S.C. 3303a(a), and list the schedules at the end of this notice by agency and subdivision requesting disposition authority. In addition, this notice lists the organizational unit(s) accumulating the records or states that the schedule has agency-wide applicability. It also provides the control number assigned to each schedule, which you will need if you submit comments on that schedule. We have uploaded the records schedules and accompanying appraisal memoranda to the regulations.gov docket for this notice as ‘‘other’’ documents. Each records schedule contains a full description of the records at the file unit level as well as their proposed disposition. The appraisal memorandum for the schedule includes information about the records. We will post comments, including any personal information and attachments, to the public docket unchanged. Because comments are public, you are responsible for ensuring that you do not include any confidential or other information that you or a third party may not wish to be publicly posted. If you want to submit a comment with confidential information or cannot otherwise use the regulations.gov portal, you may contact request.schedule@nara.gov for instructions on submitting your comment. We will consider all comments submitted by the posted deadline and consult as needed with the Federal agency seeking the disposition authority. After considering comments, E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

[Federal Register Volume 90, Number 17 (Tuesday, January 28, 2025)]
[Notices]
[Pages 8303-8304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01766]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1454]


Importer of Controlled Substances Application: Aveva Drug 
Delivery Systems, Inc.

AGENCY: Drug Enforcement Administration, Justice.

[[Page 8304]]


ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Aveva Drug Delivery Systems, Inc. has applied to be registered 
as an importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants, therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
February 27, 2025. Such persons may also file a written request for a 
hearing on the application on or before February 27, 2025.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on October 9, 2024, Aveva Drug Delivery Systems, Inc., 
3250 Commerce Parkway, Miramar, Florida 33025-3907, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Thebaine...............................     9333  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance for 
analytical purposes only. No other activity for this drug code is 
authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-01766 Filed 1-27-25; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.